ANO7 and cancer: Alternatively, technical issues such as a variable contamination with ANO7-positive normal glandular cells or ANO7-negative stromal cells, a possible selection bias for larger advanced cancers that can be more easily used for next-generation sequencing, or the comparatively low number of patients may account for these discrepant findings.